Archive
Novartis beats Q3 2017 estimate, reaffirms FY17 sales view
Pharmaceutical company Novartis AG (NYSE: NVS) reported a 2% y-o-y increase in net sales in the third-quarter of fiscal 2017. The company also recorded a 7% jump in Q3 2017 net income. Further, the September quarter results surpassed analysts’ estimates.
Read MoreInvestment banking rescues Goldman Sachs in Q3 2017
The global investment banking giant Goldman Sachs Group (NYSE: GS) reported a better-than-anticipated fiscal 2017 third-quarter results on Tuesday. Goldman Sachs also managed to beat fixed-income, currencies, and commodities (FICC) revenue estimate, while most of the major banks failed to
Read MoreNike reports 24% y-o-y decline in Q1 2018 earnings
Apparel and footwear manufacturer Nike Inc (NYSE: NKE) reported mixed fiscal 2018 first-quarter results, last Wednesday. While the revenues failed to beat estimates, the adjusted earnings surpassed expectations. A strong growth in China was mainly responsible for the company to
Read More